May. 9 at 10:16 AM
$LFMD i wish these guys would just come out and say “GLP-1s were just one peptide and are a
$100BN a year opportunity. LifeMD is going to go full steam ahead on incorporating peptides into our treatment plans and will become the de facto source for people to learn about and receive peptide treatment options”
Complete game changer. Higher risk but they need to be at the forefront of this generational pivot in treatment options, not playing catchup to HIMS/RO/AMZN